Bloomington, IN, United States of America

Bin Yang


 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Bin Yang

Introduction

Bin Yang is a prominent inventor based in Bloomington, IN (US). He has made significant contributions to the field of biochemistry and pharmacology, holding a total of 7 patents. His work primarily focuses on developing novel therapeutic peptides that target metabolic disorders.

Latest Patents

Among his latest patents, one notable invention is the "Glucagon superfamily peptides exhibiting nuclear hormone receptor activity." This patent describes glucagon superfamily peptides conjugated with nuclear hormone receptor ligands, which can act at a nuclear hormone receptor. The invention also includes pharmaceutical compositions and kits containing these conjugates, as well as methods for treating diseases such as diabetes and obesity through their administration. Another significant patent is for "Glucagon/GLP-1 receptor co-agonists," which details peptides and variant peptides that demonstrate enhanced activity at the GLP-1 receptor compared to native glucagon.

Career Highlights

Bin Yang is affiliated with Indiana University, where he conducts research and develops innovative solutions in the field of metabolic disorders. His work has garnered attention for its potential to improve treatment options for conditions like diabetes and obesity.

Collaborations

Throughout his career, Bin Yang has collaborated with notable colleagues, including Richard Dennis DiMarchi and David L Smiley. These collaborations have further advanced his research and contributed to the development of his patented inventions.

Conclusion

Bin Yang's contributions to the field of biochemistry and pharmacology through his innovative patents highlight his commitment to addressing critical health issues. His work continues to pave the way for new therapeutic approaches in treating metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…